Showing results (2381-2390 of 9,904) with videos related to
Sort By:
Pageof 991
Bone Marrow Transplantation|March 16, 2025
Improved GVHD-free and relapse-free survival after ex vivo αβTCR and CD19 depleted allogeneic HSCT compared to T cell replete HSCTA H G Stuut, C Nijssen, L van der Wagen, et al.Bone Marrow Transplantation|April 24, 2025
Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in active disease: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationSara Tarantino, Myriam Labopin, Robert Zeiser, et al.Bone Marrow Transplantation|April 22, 2025
Management of liver sinusoidal obstruction syndrome/veno-occlusive disease in adults: a 2025 perspective from an international expert groupMarion Larue, Florent Malard, Ahmed S Alaskar, et al.Bone Marrow Transplantation|April 17, 2025
CAR-T for multiple myeloma: practice pearlsDaniel O'Leary, Veronika BachanovaBone Marrow Transplantation|April 24, 2025
Risk stratification and impact of donor type on breakthrough invasive fungal infections in haematopoietic cell transplant with post-transplant cyclophosphamide and mould-active prophylaxisMatteo Chiurlo, Laura Galli, Francesca Farina, et al.Bone Marrow Transplantation|April 16, 2025
The impact of the SARS-CoV-2 pandemic on umbilical cord blood transplantation in Japan: insights from an interrupted time series analysisNobuhiko Nakamura, Tetsuji Morishita, Hiromi Hayashi, et al.Bone Marrow Transplantation|April 2, 2025
Thiotepa, busulfan and fludarabine conditioning regimen for adult patients with lymphoid malignancies undergoing allogeneic stem cell transplantation: a study on behalf of GETH-TCM Peña, D F Martinez, A Paviglianiti, et al.Bone Marrow Transplantation|April 12, 2025
Food insecurity prior to hematopoietic stem cell transplant is associated with malnutrition and worse outcomesMatthew A Bergens, Yen P Lowder, Yan Li, et al.Bone Marrow Transplantation|March 6, 2026
Anti-thymocyte globulin (ATG)- or alemtuzumab-based graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic hematopoietic cell transplantation (HCT) for patients 40 years and older with acute lymphoblastic leukemia in first complete remission: a study from the EBMT Acute Leukemia Working PartyGesine Bug, Myriam Labopin, Jennifer L Byrne, et al.Bone Marrow Transplantation|February 8, 2024
Updated comparable efficacy of cord blood transplantation for chronic myelomonocytic leukaemia: a nationwide studyShuhei Kurosawa, Yoshimitsu Shimomura, Ken Ishiyama, et al.Pageof 991